| The human adrenal cortex: growth control and disorders CFP Lotfi, JL Kremer, B dos Santos Passaia, IP Cavalcante Clinics 73 (suppl 1), e473s, 2018 | 45 | 2018 |
| TCF21/POD-1, a transcritional regulator of SF-1/NR5A1, as a potential prognosis marker in adult and pediatric adrenocortical tumors BS Passaia, MH Dias, JL Kremer, SRR Antonini, MQ Almeida, ... Frontiers in Endocrinology 9, 38, 2018 | 12 | 2018 |
| Role of the bHLH transcription factor TCF21 in development and tumorigenesis CFP Lotfi, BS Passaia, JL Kremer Brazilian Journal of Medical and Biological Research 54, e10637, 2021 | 11 | 2021 |
| Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours B dos Santos Passaia, K Lima, JL Kremer, BB da Conceição, ... Investigational New Drugs 38, 899-908, 2020 | 8 | 2020 |
| N-type calcium channel v2. 2 is a target of TCF21 in adrenocortical carcinomas. B dos Santos PASSAIA, JL Kremer, MC Villares Fragoso, CF Pacicco Lotfi Neoplasma 69 (4), 2022 | 2 | 2022 |
| Upregulation of TCF21 inhibits migration of adrenocortical carcinoma cells JL Kremer, TB Auricino, B dos Santos Passaia, CFP Lotfi Discover Oncology 12, 1-15, 2021 | | 2021 |
| Identificação de novos alvos do fator de transcrição POD1/TCF21 em culturas de células de tumores humanos. B dos Santos Passaia Universidade de São Paulo, 2020 | | 2020 |
Claudimara LotfiProfessor do Instituto de Ciências Biomédicas, Universidade de São Paulo在 usp.br 的电子邮件经过验证
Claudimara LotfiProfessor do Instituto de Ciências Biomédicas, Universidade de São Paulo在 usp.br 的电子邮件经过验证